Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arcoma is a Swedish medical technology company focused on digital radiography and radiology solutions. The name "Arcoma-IMIX" appears to refer to the combined business created through the 2010 merger of Arcoma and IMIX, but the currently active operating company is Arcoma. The company develops, manufactures, and commercializes complete digital X-ray systems, radiography subsystems, and related workflow-enhancing solutions for hospitals, clinics, imaging centers, OEM customers, and distributors worldwide. Its portfolio includes premium and modular DR systems such as Precision i5 and Intuition i3, and it emphasizes ergonomic design, auto-positioning, and integrated imaging workflows. Arcoma is ISO 13485 certified, states compliance with FDA QSR Part 820, and markets CE-marked products under the EU MDR framework. The business is commercial-stage and derives revenue from the sale of diagnostic imaging equipment rather than from a therapeutic drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arcoma-IMIX.